Cardiac Biomarkers Are Associated With an Increased Risk of Stroke and Death in Patients With Atrial Fibrillation: A Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Substudy

Hijazi, Ziad, Oldgren, Jonas, Andersson, Ulrika, Connolly, Stuart J., Ezekowitz, Michael D., Hohnloser, Stefan H., Reilly, Paul A., Vinereanu, Dragos, Siegbahn, Agneta, Yusuf, Salim, Wallentin, Lars·2012·Circulation
DOI 10.1161/circulationaha.111.038729

Cited by (400)

Items 201–300 of 400

  1. Troponin-I Is a Predictor of a Delayed Diagnosis of Atrial Fibrillation in Acute Ischemic Stroke and Transient Ischemic Attack
    Frank Ward, Rory McGovern, Paul E Cotter · 2014 · Journal of Stroke and Cerebrovascular Diseases
  2. Atrial Fibrillation: Biomarkers Determining Prognosis
    Savas Mazaris, Gerasimos Siasos, Evangelos K. Oikonomou, Vicky Tsigkou, Manolis Vavuranakis, Eleni Kokkou, Marina Zaromitidou, George-Angelo Papamikroulis, Athanasios G. Papavassiliou, Spyridon Papaioannou et al. · 2017 · Current Medicinal Chemistry
  3. N-terminal pro-B-type natriuretic peptide and the risk of stroke among patients hospitalized with acute heart failure: an APEX trial substudy
    Gerald Chi, James L. Januzzi, Serge Korjian, Yazan Daaboul, Samuel Zachary Goldhaber, Adrian F. Hernandez, Russell Douglas Hull, Alex Gold, Alexander Thomas Cohen, Robert A. Harrington et al. · 2017 · Journal of Thrombosis and Thrombolysis
  4. Troponins: established and novel indications in the management of cardiovascular disease
    Evangelos Giannitsis, Hugo Albert Katus · 2018 · Heart
  5. Coronary atherosclerosis and adverse outcomes in patients with recent-onset atrial fibrillation and troponin rise
    Alberto Conti, Elena Angeli, Margherita Scorpiniti, Andrea Alesi, Federica Trausi, Delia Lazzeretti, Luigi Padeletti, Gian Franco Gensini · 2015 · The American Journal of Emergency Medicine
  6. Optimum Risk Assessment for Stroke in Atrial Fibrillation: Should We Hold the Status Quo or Consider Magnitude Synergism and Left Atrial Appendage Anatomy?
    James A. Reiffel · 2017 · Arrhythmia & Electrophysiology Review
  7. Biomarkers in electrophysiology: role in arrhythmias and resynchronization therapy
    Abhishek Bose, Quynh A. Truong, Jagmeet P. Singh · 2015 · Journal of Interventional Cardiac Electrophysiology
  8. Cardiac Remodeling, Circulating Biomarkers and Clinical Events in Patients with a History of Atrial Fibrillation. Data from the GISSI-AF Trial
    on the behalf of the GISSI-AF Investigators, Lidia Irene Staszewsky, Serge Masson, Simona Barlera, Marcello Disertori, Silvana Boni, Daniele Bertoli, Olga Vriz, Elena Pasotti, Prisca Zeni et al. · 2015 · Cardiovascular Drugs and Therapy
  9. Pharmacological and Non-pharmacological Treatments for Stroke Prevention in Patients with Atrial Fibrillation
    Laura Ueberham, Nikolaos Dagres, Tatjana Potpara, Andreas Bollmann, Gerhard Hindricks · 2017 · Advances in Therapy
  10. High sensitivity troponin in the management of tachyarrhythmias
    Mark Mariathas, Cameron Gemmell, Bartosz Olechowski, Zoe Nicholas, Michael Mahmoudi, Nick P. Curzen · 2017 · Cardiovascular revascularization medicine
  11. High-sensitivity cardiac troponin I and risk of incident atrial fibrillation hospitalisation in an Australian community-based cohort: The Busselton health study
    Kun Zhu, Joseph Hung, Mark Divitini, Kevin Murray, Ee Mun Lim, Andrew St John, John P. Walsh, Matthew William Knuiman · 2018 · Clinical Biochemistry
  12. Correlation of Serum Cardiac Markers with Acute Decompensating Events in Liver Cirrhosis
    Miaomiao Li, Zeqi Guo, Dan Zhang, Xiangbo Xu, Fernando Gomes Romeiro, Andrea Mancuso, Jingqiao Zhang, Ruirui Feng, Xinmiao Zhou, Cen Hong et al. · 2020 · Gastroenterology Research and Practice
  13. The Role of Biochemical Cardiac Markers in Atrial Fibrillation
    Saira Rafaqat, Sana Rafaqat, Hafsa Ijaz · 2023 · Journal of Innovations in Cardiac Rhythm Management
  14. Evaluation of the Age, Biomarkers, and Clinical History–Bleeding Risk Score in Patients With Atrial Fibrillation With Combined Aspirin and Anticoagulation Therapy Enrolled in the ARISTOTLE and RE-LY Trials
    Ziad Hijazi, Jonas Oldgren, Johan Lindbäck, John Hunter Alexander, Marco Alings, Raffaele De Caterina, John W. Eikelboom, Michael D. Ezekowitz, Claes Held, Kurt Huber et al. · 2020 · JAMA Network Open
  15. Duration of atrial fibrillation and cardiac biomarkers are associated with cardiovascular outcomes in early permanent atrial fibrillation: Data from the RACE II study
    Marieke J H Velt, Isabelle C. Van Gelder, Harry J.G.M. Crijns, Michiel Rienstra, Bart A. Mulder · 2025 · International Journal of Cardiology
  16. Risk stratification of patients with atrial fibrillation: Biomarkers and other future perspectives
    Rui Andre Providencia · 2012 · World Journal of Cardiology
  17. Most Important Outcomes Research Papers on Stroke and Transient Ischemic Attack
    Rachel P. Dreyer, Karthik Murugiah, Sudhakar V. Nuti, Kumar Dharmarajan, Serene I. Chen, Ruijun Chen, Brian J. Wayda, Isuru Ranasinghe · 2014 · Circulation Cardiovascular Quality and Outcomes
  18. Cardiac Biomarkers and Subsequent Risk of Hospitalization With Bleeding in the Community: Atherosclerosis Risk in Communities Study
    Lena M. Mathews, Junichi Ishigami, Ning Ding, Ron Cornelis Hoogeveen, Anna Kucharska‐Newton, Christie Mitchell Ballantyne, Rebecca F. Gottesman, Elizabeth Selvin, Kunihiro Matsushita · 2020 · Journal of the American Heart Association
  19. Coagulation Biomarkers and Clinical Outcomes in Elderly Patients With Nonvalvular Atrial Fibrillation
    Yukihiro Koretsune, Takeshi Yamashita, Masaharu Akao, Hirotsugu Atarashi, Takanori Ikeda, Ken Okumura, Wataru Shimizu, Shinya S. Suzuki, Hiroyuki Tsutsui, Ḱazunori Toyoda et al. · 2023 · JACC Asia
  20. Prognostic Value of Serum N-Terminal Pro-Brain Natriuretic Peptide Level over Heart Failure for Stroke Events and Deaths in Patients with Atrial Fibrillation
    Keiichiro Kuronuma, Yasuo Okumura, Tomoyuki Morikawa, Katsuaki Yokoyama, Naoya Matsumoto, Eizo Tachibana, Koji Oiwa, Michiaki Matsumoto, Toshiaki Kojima, Hironori Haruta et al. · 2020 · International Heart Journal
  21. Association of stroke risk biomarkers with stroke symptoms: the Reasons for Geographic and Racial Differences in Stroke cohort
    Kara K. Landry, Kristine Alexander, Neil A. Zakai, Suzanne E. Judd, Dawn Kleindorfer, Virginia J. Howard, George Howard, Mary Cushman · 2016 · Journal of Thrombosis and Haemostasis
  22. Stroke Risk Predictor Scoring Systems in Atrial Fibrillation.
    Tze‐Fan Chao, M D Chen · 2014 · Europe PMC (PubMed Central)
  23. Improving stroke risk prediction in atrial fibrillation with circulating biomarkers: the CHA2DS2-VASc–Biomarkers model
    Samuel Short, Katherine S. Wilkinson, Erin Mathiesen Hald, George Howard, Virginia J. Howard, Suzanne E. Judd, Elsayed Z. Soliman, Brett M. Kissela M. D, David Robinson, Robert J. Stanton et al. · 2025 · Journal of Thrombosis and Haemostasis
  24. Stroke and Bleeding Risk Assessment in Atrial Fibrillation: Where Are We Now?
    Ling Kuo, Yi‐Hsin Chan, Jo‐Nan Liao, Shih‐Ann Chen, Tze‐Fan Chao · 2021 · Korean Circulation Journal
  25. Predictive Role of BNP/NT-proBNP in Non-Heart Failure Patients Undergoing Catheter Ablation for Atrial Fibrillation: An Updated Systematic Review
    Νικόλαος Παπαγεωργίου, Rui Andre Providencia, Debbie Falconer, Tanakal Wongwarawipat, Dimitris Tousoulis, Wei Yao Lim, ANTHONY W.C. CHOW, RICHARD JOHN SCHILLING, Pier David Lambiase · 2019 · Current Medicinal Chemistry
  26. Moderate Levels of N-Terminal Pro-B-Type Natriuretic Peptide is Associated with Increased Risks of Total and Ischemic Strokes among Japanese: The Circulatory Risk in Communities Study
    Kenji Ebihara, Kazumasa Yamagishi, Mitsumasa Umesawa, Isao Muraki, Renzhe Cui, Hironori Imano, Yasuhiko Kubota, Mina Hayama‐Terada, Yūji Shimizu, Tetsuya Ohira et al. · 2020 · Journal of Atherosclerosis and Thrombosis
  27. Performance of the Cockcroft-Gault, MDRD and CKD-EPI Formulae in Non-Valvular Atrial Fibrillation: Which one Should be Used for Risk Stratification?
    Sérgio Barra, Rui Andre Providencia, Catarina Faustino, Luís Paiva, Andréia Silva Fernandes, António Leitão Marques · 2013 · Europe PMC (PubMed Central)
  28. Is the true clinical value of high-sensitivity troponins as a biomarker of risk? The concept that detection of high-sensitivity troponin ‘never means nothing’
    Jonathan Hinton, Lavinia Gabara, Nick P. Curzen · 2020 · Expert Review of Cardiovascular Therapy
  29. N‐terminal pro‐B‐type natriuretic peptide and D‐dimer combined with left atrial diameter to predict the risk of ischemic stroke in nonvalvular atrial fibrillation
    Zican Shen, Dong Chen, Hao Cheng, Feng Tan, Jianwei Yan, Haiming Deng, Wei Fang, Sunan Wang, Jianbing Zhu · 2022 · Clinical Cardiology
  30. Assessment of N-terminal pro-B-type natriuretic peptide level in screening for atrial fibrillation in primary health care
    Faris Ghazal, Holger Theobald, Mårten Rosenqvist, Faris Al-Khalili · 2019 · PLoS ONE
  31. Association of natriuretic peptide and adverse outcomes in patients with atrial fibrillation: A meta‐analysis
    Hong Du, Lei Yang, Hui Zhang, Xiaolin Zhang, Huiyu Shao · 2020 · Clinical and Experimental Pharmacology and Physiology
  32. Prognostic value of interleukin-34 and interleukin-38 in patients with newly diagnosed atrial fibrillation
    Jiaxue Ma, Na Wu, Zhiquan Yuan, Yanxiu Chen, Chengying Li, Weijia Xie, Zhihui Zhang, Yafei Li, Li Zhong · 2023 · Frontiers in Cardiovascular Medicine
  33. Neuroglial Biomarkers for Risk Assessment of Ischemic Stroke and Other Cardiovascular Events in Patients With Atrial Fibrillation Not Receiving Oral Anticoagulation
    Julia Aulin, Karl Sjölin, Johan Lindbäck, Alexander Philipp Benz, John W. Eikelboom, Kim Kultima, Jonas Oldgren, Lars C. Wallentin, Joachim Burman · 2024 · Journal of the American Heart Association
  34. Stroke Prevention in Atrial Fibrillation
    Xu Gao, ROD S. PASSMAN · 2022 · Current Cardiology Reports
  35. The Role of Natriuretic Peptides: From the Emergency Department Throughout Hospitalization
    Peter S. Pang, Yang Xue, Christopher R. deFilippi, Marc T. Silver, James L. Januzzi, Alan S. Maisel · 2012 · Congestive Heart Failure
  36. Rhythm outcomes after catheter ablation of atrial fibrillation
    Jelena Kornej, Daniela Husser, Andreas Bollmann, Gregory Y.H. Lip · 2013 · Hämostaseologie
  37. Role of New Potential Biomarkers in the Risk of Thromboembolism in Atrial Fibrillation
    Mario Piergiulio Pezzo, Antonella Tufano, Massimo Franchini · 2022 · Journal of Clinical Medicine
  38. Structural Cardiac Abnormalities in Patients with Atrial Fibrillation/Flutter and Myocardial Injury
    Laura De Michieli, Ronstan Lobo, Luciano Babuin, Rowlens M. Melduni, Sabino Iliceto, Abhiram Prasad, Yader B. Sandoval, Allan S. Jaffe · 2022 · The American Journal of Medicine
  39. Atrial Fibrillation: A Review of Recent Studies with a Focus on Those from the Duke Clinical Research Institute
    Meena P. Rao, Sean D. Pokorney, Christopher Bull Granger · 2014 · Scientifica
  40. Fine Tuning Risk Stratification for Atrial Fibrillation
    Richard William Troughton, Ian Crozier · 2013 · Journal of the American College of Cardiology
  41. Determinants of Left Atrial Volume in Patients with Atrial Fibrillation
    Matthias Bossard, Rahel Kreuzmann, Thomas Hochgruber, Philipp Krisai, Andreas J. Zimmermann, Stefanie Aeschbacher, Katrin Pumpol, Arnheid Kessel-Schaefer, Frank‐Peter Stephan, Nadja Handschin et al. · 2016 · PLoS ONE
  42. Biomarkers Associated with Bleeding Risk in the Setting of Atrial Fibrillation
    Skevos K. Sideris, Stefanos Archontakis, George Latsios, George A. Lazaros, Konstantinos P. Toutouzas, Eleftherios G. Tsiamis, Manolis Vavuranakis, Charalampos Vlachopoulos, Konstantinos A. Gatzoulis, Constantinos Tsioufis et al. · 2017 · Current Medicinal Chemistry
  43. The Year in Review of Clinical Cardiac Electrophysiology
    Gregory M. Marcus, Edmund C. Keung, Melvin M. Scheinman · 2013 · Journal of the American College of Cardiology
  44. Impact of atrial fibrillation on levels of high-sensitivity troponin I in a 75-year-old population
    Anja Wiedswang Horjen, Sara Reinvik Ulimoen, Steve Enger, Trygve Berge, Håkon Ihle‐Hansen, Jon Norseth, Arnljot Tveit · 2015 · Scandinavian Journal of Clinical and Laboratory Investigation
  45. Biomarkers in the risk assessment for stroke and dementia in atrial fibrillation
    Oxana Galenko, Victoria Jacobs, Thomas Jared Bunch · 2019 · Current Opinion in Cardiology
  46. Growth differentiation factor 15 as an integral marker of the clinical and functional status of patients with non-valvular atrial fibrillation
    Tatiana P. Gizatulina, L. U. Martyanova, Tatiana Ivanovna Petelina, Е. В. Зуева, Широков Никита Евгеньевич · 2020 · Journal of Arrhythmology
  47. The ABC-Stroke Score Refines Stroke Risk Stratification in Patients With Atrial Fibrillation at the Emergency Department
    Jan Daniel Niederdöckl, Julia Oppenauer, Sebastian Schnaubelt, Filippo Cacioppo, Nina Buchtele, Alexandra-Maria Warenits, Roberta Laggner, Nikola Schütz, Magdalena Sophie Boegl, Gerhard Ruzicka et al. · 2022 · Frontiers in Medicine
  48. Longitudinal analysis of echocardiographic and cardiac biomarker variables in dogs with atrial fibrillation: The optimal rate control in dogs with atrial fibrillation II study
    Brigite Pedro, Antonia Mavropoulou, Mark A. Oyama, Chris Linney, J. Neves, Joanna Dukes‐McEwan, Ana Patrícia Fontes-Sousa, Anna R. Gelzer · 2024 · Journal of Veterinary Internal Medicine
  49. High-Sensitivity Troponin: Where are We Now and Where do We Go from Here?
    Frederick Kofi Korley, Allan S. Jaffe · 2014 · Biomarkers in Medicine
  50. Troponin rise in patients with atrial fibrillation: A marker of adverse prognosis and increased thromboembolic risk
    Rui Andre Providencia, Luís Paiva, Sérgio Barra, Ana Faustino · 2013 · International Journal of Cardiology
  51. Growth Differentiation Factor 15 and Risk of Bleeding Events: The Atherosclerosis Risk in Communities Study
    Lena M. Mathews, Xiao Feng Hu, Ning Ding, Junichi Ishigami, Mahmoud Al Rifai, Ron Cornelis Hoogeveen, Josef Coresh, Christie Mitchell Ballantyne, Elizabeth Selvin, Kunihiro Matsushita · 2023 · Journal of the American Heart Association
  52. Diltiazem reduces levels of NT-proBNP and improves symptoms compared with metoprolol in patients with permanent atrial fibrillation
    Katrine Enge, Arnljot Tveit, Steve Enger, Sophia Onarheim, Are Hugo Pripp, Peter Selmer Rønningen, Magnar Gangås Solberg, Rune Byrkjeland, Kristoffer Andresen, Anders Halsen et al. · 2024 · European Heart Journal - Cardiovascular Pharmacotherapy
  53. Impact of BNP level and peak VO2 on future heart failure events: comparison between sinus rhythm and atrial fibrillation
    Yuko Kato, Shinya S. Suzuki, Tokuhisa Uejima, Hiroaki Semba, Hiroto Kano, Shunsuke Matsuno, Hideaki Takai, Takayuki Otsuka, Yuji Oikawa, Kazuyuki Nagashima et al. · 2016 · Heart and Vessels
  54. Atrial cardiomyopathy: Diagnosis, clinical implications and unresolved issues in anticoagulation therapy
    Ourania K. Kariki, Konstantinos George Vlachos, Stylianos Dragasis, Eleftheria-Garyfallia Tsetika, Kalliopi Perlepe, Athanasios Saplaouras, Eva G. Nyktari, Michael Efremidis, Κonstantinos P. Letsas · 2022 · Journal of Electrocardiology
  55. Serum Catestatin Concentrations Are Increased in Patients with Atrial Fibrillation
    Josip Katić, Zrinka Jurišić, Marko Kumrić, Josip A. Borovac, Ante Anić, Toni Brešković, Daniela Šupe‐Domić, Joško Božić · 2023 · Journal of Cardiovascular Development and Disease
  56. The ABC‐Stroke Risk Score and Effects of Atrial Fibrillation Screening on Stroke Prevention: Results From the Randomized LOOP Study
    Lucas Yixi Xing, Søren Zöga Diederichsen, Søren Højberg, Derk Wolfgang Krieger, Claus Graff, Ruth Frikke‐Schmidt, Pyotr G. Platonov, MORTEN SALLING OLESEN, Axel Brandes, Lars Køber et al. · 2024 · Journal of the American Heart Association
  57. Relationship of inflammatory indices with left atrial appendage thrombus or spontaneous echo contrast in patients with atrial fibrillation
    Zhao Wang, Binhao Wang, Xiaolei Yang, Yunlong Xia, Shengmin Zhang, Ying Che · 2024 · World Journal of Clinical Cases
  58. The role of NT-proBNP in screening for atrial fibrillation in hypertensive disease
    Gina Sado, Katrin Kemp Gudmundsdottir, Carl Bonander, Mattias Ekström, Johan Engdahl, Emma Svennberg · 2024 · IJC Heart & Vasculature
  59. A review of apixaban for stroke prevention in atrial fibrillation: insights from ARISTOTLE
    Connie Ng Hess, Sana M. Al‐Khatib, Christopher Bull Granger, Renato D. Lópes · 2013 · Expert Review of Cardiovascular Therapy
  60. New Oral Anticoagulants in Heart Failure
    Isabelle C. Van Gelder, Dirk Jan van Veldhuisen, Gregory Y.H. Lip · 2013 · European Journal of Heart Failure
  61. Paroxysmal Atrial Fibrillation: Novel Strategies for Monitoring and Implications for Treatment in Stroke
    Scott B. Silverman · 2016 · Current Treatment Options in Cardiovascular Medicine
  62. Escalas de evaluación del riesgo tromboembólico y hemorrágico en la fibrilación auricular
    Javier Pérez Copete, María Asunción Esteve‐Pastor, Vanessa Roldán, Mariano Valdés, Francisco R. Marín · 2016 · Revista Española de Cardiología Suplementos
  63. Value of Combining Left Atrial Diameter and Amino-terminal Pro-brain Natriuretic Peptide to the CHA2DS2-VASc Score for Predicting Stroke and Death in Patients with Sick Sinus Syndrome after Pacemaker Implantation
    Bin‐Feng Mo, Qiu‐Fen Lu, Shang-biao Lu, Yuquan Xie, Xiang‐Fei Feng, Yi‐Gang Li · 2017 · Chinese Medical Journal
  64. High Cardiac Troponin I Is Associated With Transesophageal Echocardiographic Risk of Thromboembolism and Ischemic Stroke Events in Non-Valvular Atrial Fibrillation Patients
    Shuhei Tanaka, Tadakazu Hirai, Kyoko Inao, Nobuyuki Fukuda, Keiko Nakagawa, Hiroshi Inoue, Koichiro Kinugawa · 2018 · Circulation Journal
  65. Betrixaban for Extended Venous Thromboembolism Prophylaxis in High-Risk Hospitalized Patients: Putting the APEX Results into Practice
    Kayla M. Miller, Michael J. Brenner · 2019 · Drugs
  66. Clinical use of cardiac troponin for acute cardiac care and emerging opportunities in the outpatient setting
    Yader B. Sandoval, Korosh Sharain, Amy K. Saenger, Stephen W. Smith, Fred S. Apple, Allan S. Jaffe · 2019 · Minerva Medica
  67. Prognostic value of troponin I in atrial fibrillation
    Aurelio Quesada, Lucas López-Valero, Goitzane Marcaida, Javier Jiménez Bello, Javier Quesada-Ocete, Ricardo Rubini-Costa, Blanca Quesada-Ocete, Ricardo Rubini-Puig, Ángeles Férez Martí, Víctor Del-Moral-Ronda et al. · 2021 · Progress in Cardiovascular Diseases
  68. The level of growth differentiation factor 15 as a predictor of left atrial thrombosis in patients with nonvalvular atrial fibrillation
    Tatiana P. Gizatulina, N. Yu. Khorkova, L. U. Martyanova, Tatiana Ivanovna Petelina, Е. В. Зуева, Широков Никита Евгеньевич, Д. В. Криночкин, Е. А. Горбатенко · 2021 · Kardiologiia
  69. Troponin I levels in permanent atrial fibrillation—impact of rate control and exercise testing
    Anja Wiedswang Horjen, Sara Reinvik Ulimoen, Steve Enger, Jon Norseth, Ingebjørg Seljeflot, Harald Arnesen, Arnljot Tveit · 2016 · BMC Cardiovascular Disorders
  70. Atrial fibrillation: is there a role for cardiac troponin?
    Alireza Sepehri Shamloo, Arash Arya, Angeliki Darma, Sotirios Nedios, Michael Döring, Andreas Bollmann, Nikolaos Dagres, Gerhard Hindricks · 2020 · Diagnosis
  71. Higher N-Terminal Pro–B-Type Natriuretic Peptide May Be Related to Very Different Conditions
    Şevket Balta, Saıt Demırkol, Mehmet Aydogan, Turgay Celık · 2013 · Journal of the American College of Cardiology
  72. Unrecognized myocardial infarction and cardiac biochemical markers in patients with stable coronary artery disease
    Anna M. Nordenskjöld · 2016 · Diva portal (Dalarna University Library)
  73. Natriuretic peptide should be used as a routine tool for evaluation of patients with atrial fibrillation
    Ziad Hijazi, Lars C. Wallentin · 2018 · Heart
  74. Association of atrial fibrillation burden and clinical profile with blood biomarkers: Results from the ISOLATION Ablation Cohort
    Z Habibi, Dominique V. M. Verhaert, Konstanze Betz, B J M Hermans, Joris Winters, Suzanne Philippens, Sevasti‐Maria Chaldoupi, Bart A. E. Maesen, Jos G. Maessen, Aaron J. Isaacs et al. · 2025 · Heart Rhythm O2
  75. The predictive role of N-terminal pro-B-type natriuretic peptide in assessing outcomes for atrial fibrillation patients, with or without heart failure: a comprehensive systematic review and meta-analysis
    Afina Syarah Lidvihurin, Yusuf Ananda Fikri · 2024 · Cardiology Plus
  76. Bleeding risk assessment tools in patients with atrial fibrillation taking anticoagulants: a comparative review and clinical implications
    Chia Siang Kow, Feng Chen, Shawn Kai Jie Leong, Kai Yuan Tham, L. Yeoh, Ze Ming Chew, Wen Jie Peh, Kaeshaelya Thiruchelvam · 2025 · Expert Review of Cardiovascular Therapy
  77. Troponin T Predicts Cardioembolic Aetiology and Clinical Outcome in Undetermined Ischaemic Stroke in Hyperacute Phase
    Mikel Terceño, Yolanda Silva, Saima Bashir, Víctor A Vera-Monge, María Buxó, Joaquin L Serena · 2019 · Journal of Stroke and Cerebrovascular Diseases
  78. Role of circulating long non-coding RNA for the improvement of the predictive ability of the CHA2DS2–VASc score in patients with atrial fibrillation
    Yuanbo Zhang, Duan Wang, Na Wu, Xinghua Chen, Zhiquan Yuan, Xiaoyue Jia, Chengying Li, Qin Hu, Yanxiu Chen, Zhihui Zhang et al. · 2022 · Chinese Medical Journal
  79. Value of N-Terminal Pro-Brain Natriuretic Peptide for Embolic Events Risk Prediction in Patients with Atrial Fibrillation; a Systematic Review and Meta-Analysis.
    Koohyar Ahmadzadeh, Amirali Hajebi, Hamzah Adel Ramawad, Yaser Azizi, Mahmoud Yousefifard · 2023 · Archives of Academic Emergency Medicine
  80. Hypertension and Atrial Fibrillation
    Alberto Conti, Andrea Alesi, Federica Trausi, Margherita Scorpiniti, Elena Angeli, Sofia Bigiarini, Simone Bianchi, Chiara Donnini, Delia Lazzeretti, Luigi Padeletti · 2014 · Critical Pathways in Cardiology A Journal of Evidence-Based Medicine
  81. High-Sensitivity Troponin T For The Risk Assessment Of Patients With Acute Atrial Fibrillation
    Marcia M Cortes, Rosina Arbucci, Florencia Lambardi, Juan Furmento, Florencia Muñoz, Marcos Viruel, Bryce Alexander, Adrian M Baranchuk, Juan Pablo Costabel · 2021 · Current Problems in Cardiology
  82. Cardiac troponins and adverse outcomes in European patients with atrial fibrillation: A report from the ESC-EHRA EORP atrial fibrillation general long-term registry
    Marco Vitolo, Vincenzo Livio Malavasi, Marco Proietti, Igor Diemberger, Laurent Fauchier, Francisco R. Marín, Michael Näbauer, Tatjana Potpara, Gheorghe‐Andrei Dan, Zbigniew F. Kalarus et al. · 2022 · European Journal of Internal Medicine
  83. Prognosis of elderly non-valvular atrial fibrillation patients stratified by B-type natriuretic peptide: ELDERCARE-AF subanalysis
    Osamu Okazaki, Yorihiko Higashino, Koichi Yokoya, Yoshimori An, Kimihiko Tanizawa, Yuki Imamura, Takuya Hayashi, Masaharu Akao, Ken Okumura, Takeshi Yamashita · 2022 · American Heart Journal
  84. Association between circulating biomarkers and atrial fibrillation burden in patients with paroxysmal atrial fibrillation: a subanalysis of the RACE V study
    Maria Hee Jung Park Frausing, Michiel Rienstra, Mads Brix Kronborg, Mirko De Melis, Ulrich Schotten, Jens C Nielsen, Robert G. Tieleman, Harry J.G.M. Crijns, Isabelle C. Van Gelder, Michelle Samuel · 2025 · Open Heart
  85. Molecular and Neuroimaging Profile Associated with the Recurrence of Different Types of Strokes: Contribution from Real-World Data
    Crhistian‐Mario Oblitas, Ana Sampedro‐Viana, Sabela Fernández‐Rodicio, Manuel Rodríguez‐Yáñez, Iria López‐Dequidt, Arturo González‐Quintela, Antonio J. Mosqueira, Jacobo Porto-Álvarez, Javier Martínez Fernández, Inmaculada González-Simón et al. · 2025 · Journal of Clinical Medicine
  86. Improvement in risk prediction for patients with atrial fibrillation and intermediate-risk CHA2DS2-VASc score utilizing highly sensitive cardiac troponin T
    Christian Salbach, Mustafa Yıldırım, Barbara Ruth Milles, Hauke Hund, Matthias Mueller‐Hennessen, Norbert Frey, Hugo Albert Katus, Evangelos Giannitsis · 2025 · PLoS ONE
  87. The Pros and Cons of Mendelian Randomization Studies to Evaluate Emerging Cardiovascular Risk Factors
    Jainy J. Savla, Ian J. Neeland · 2018 · Current Cardiovascular Risk Reports
  88. D-dimer and fibrinogen indicate ischemic risk in patients with atrial fibrillation after percutaneous coronary intervention
    Diona Gjermeni, Viktoria Anfang, Sofia Szabó, H Vetter, Ana C Venhoff, Stefan Leggewie, David Hesselbarth, Dietmar Trenk, Martin Buechsel, Dirk Westermann et al. · 2024 · Thrombosis Journal
  89. Predictive Value of N-Terminal Pro B-Type Natriuretic Peptide for Short-Term Outcome of Cardioversion in Patients with First-Diagnosed or Paroxysmal Atrial Fibrillation Presenting to the Emergency Department
    A Diakantonis, Christos Verras, Sofia Bezati, Vasiliki Bistola, Ioannis Ventoulis, Maria Velliou, Antonios Boultadakis, Ignatios Ikonomidis, John Parissis, Effie Polyzogopoulou · 2024 · Biomedicines
  90. Almanac 2015: atrial fibrillation research in Heart
    Muhammad Jawad Ul Qamar, Paulus F. Kirchhof · 2016 · Heart
  91. Can biomarkers balance stroke and bleeding risk?
    Paulus F. Kirchhof, Larissa Fabritz · 2016 · The Lancet
  92. Association of Serum Troponin Obtained During Stroke Codes with Cardioembolic Strokes
    Taha Nisar, Stephen S. Kamin · 2019 · Journal of Stroke and Cerebrovascular Diseases
  93. The ABC-Death Score for Mortality Prediction in Patients With Atrial Fibrillation Undergoing Catheter Ablation
    Yufeng Wang, Chao Jiang, Liu He, Xin Du, Xueyuan Guo, Ribo Tang, Caihua Sang, Deyong Long, Jianzeng Dong, Gregory Y.H. Lip et al. · 2023 · JACC Asia
  94. Patients with atrial fibrillation complicated by coronary artery disease
    Dirk Bandorski, Harilaos Bogossian, Olaf Braun, Gerrit Frommeyer, Markus Zarse, Reinhard Höltgen, Christoph Liebetrau · 2015 · Herzschrittmachertherapie + Elektrophysiologie
  95. Risk Assessment of Stroke in Patients with Atrial Fibrillation: Current Shortcomings and Future Directions
    Daniel A. Hyman, Vince Siebert, Xiaoming Jia, Mahboob Alam, Glenn N. Levine, Salim S. Virani, Yochai Birnbaum · 2019 · Cardiovascular Drugs and Therapy
  96. Risk stratification of patients with atrial fibrillation in the emergency department
    Chloe F.C. Yeo, Huihua Li, Zhi Xiong Koh, Nan Liu, Marcus Eng Hock Ong · 2020 · The American Journal of Emergency Medicine
  97. Long Troponin T to Separate Troponin Elevations Among Patients With Atrial Fibrillation Versus Myocardial Infarction
    K E J Airaksinen, Konsta Teppo, Tuija Vasankari, Tuomas Paana, Helea Junes, Selma M Salonen, T. Tuominen, Sara Simonen, Marjatta Strandberg, Tapio Hellman et al. · 2026 · Journal of the American Heart Association
  98. Routinely available inflammation biomarkers to predict stroke and mortality in atrial fibrillation
    Long Wu, Zhiquan Yuan, Yuhong Zeng, Lanqing Yang, Qin Hu, Huan Zhang, Chengying Li, Yanxiu Chen, Zhihui Zhang, Li Zhong et al. · 2025 · Clinics
  99. Sex-specific differences in left atrial reverse remodelling after successful catheter ablation for atrial fibrillation
    Yuriko Yoshida, Koki Nakanishi, Masao Daimon, Kazutoshi Hirose, Kentaro Iwama, Yasuhiro Mukai, Yuko Yamamoto, Hikari Seki, Megumi Hirokawa, Tomoko Nakao et al. · 2025 · European Heart Journal - Cardiovascular Imaging
  100. High sensitivity cardiac troponin T and interleukin‐6 predict adverse cardiovascular events and mortality in anticoagulated patients with atrial fibrillation: a reply to a rebuttal
    Vanessa Roldán, Francisco R. Marín, Pilar Gallego, Vicente Vicente, Gregory Y.H. Lip · 2012 · Journal of Thrombosis and Haemostasis